The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 02, 2020

Filed:

Feb. 21, 2005
Applicants:

Ian S. Zagon, Hummelstown, PA (US);

Patricia J. Mclaughlin, Harrisburg, PA (US);

Jill P. Smith, Camp Hill, PA (US);

Inventors:

Ian S. Zagon, Hummelstown, PA (US);

Patricia J. McLaughlin, Harrisburg, PA (US);

Jill P. Smith, Camp Hill, PA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 8/00 (2006.01); A61K 9/00 (2006.01); A61K 38/08 (2019.01); A61K 31/00 (2006.01); A61K 31/138 (2006.01); A61K 31/337 (2006.01); A61K 31/4745 (2006.01); A61K 31/505 (2006.01); A61K 31/525 (2006.01); A61K 31/573 (2006.01); A61K 31/66 (2006.01); A61K 31/663 (2006.01); A61K 31/704 (2006.01); A61K 31/7048 (2006.01); A61K 31/7072 (2006.01); A61K 31/7076 (2006.01); A61K 41/00 (2020.01); A61K 45/06 (2006.01); A61K 38/33 (2006.01); A61K 31/282 (2006.01); A61K 31/513 (2006.01); A61K 31/7068 (2006.01); A61K 51/00 (2006.01); A61N 5/10 (2006.01);
U.S. Cl.
CPC ...
A61K 38/08 (2013.01); A61K 31/00 (2013.01); A61K 31/138 (2013.01); A61K 31/282 (2013.01); A61K 31/337 (2013.01); A61K 31/4745 (2013.01); A61K 31/505 (2013.01); A61K 31/513 (2013.01); A61K 31/525 (2013.01); A61K 31/573 (2013.01); A61K 31/66 (2013.01); A61K 31/663 (2013.01); A61K 31/704 (2013.01); A61K 31/7048 (2013.01); A61K 31/7068 (2013.01); A61K 31/7072 (2013.01); A61K 31/7076 (2013.01); A61K 38/33 (2013.01); A61K 41/00 (2013.01); A61K 45/06 (2013.01); A61K 51/00 (2013.01); A61N 5/10 (2013.01); A61K 2121/00 (2013.01);
Abstract

The present invention relates to pharmaceutical compositions for treating neoplasias in an animal or human comprised of a carrier and therapeutically effective amounts of at least one chemotherapeutic agent along with the biotherapeutic endogenous pentapeptide Met-enkephalin, referred to as opioid growth factor. Also provided are methods of treating neoplasias in an animal or human in need of such treatment, comprising the administration to the animal or human therapeutically effective amounts of a pharmaceutical composition comprised of a carrier and therapeutically effective amounts of at least one neoplasia-treating agent, such as a chemotherapeutic agent or radiation, along with opioid growth factor.


Find Patent Forward Citations

Loading…